Einloggen

Thematische Bibliographien / Prognosis factor / Bücher

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Prognosis factor.

Bücher zum Thema „Prognosis factor“

Autor: Grafiati

Veröffentlicht am 29. März 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Bücher für die Forschung zum Thema "Prognosis factor" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Bücher für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Gospodarowicz, M. K., D. E. Henson, R. V. P. Hutter, B. O'Sullivan, L. H. Sobin und Ch Wittekind, Hrsg. Prognostic Factors in Cancer. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2003. http://dx.doi.org/10.1002/0471463736.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Hermanek, P., Mary K. Gospodarowicz, D. E. Henson, R. V. P. Hutter und L. H. Sobin, Hrsg. Prognostic Factors in Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79395-0.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

K, Gospodarowicz M., und International Union against Cancer, Hrsg. Prognostic factors in cancer. 2. Aufl. New York: Wiley-Liss, 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

K, Gospodarowicz M., O'Sullivan B und Sobin L. H, Hrsg. Prognostic factors in cancer. 3. Aufl. Hoboken: Wiley, 2006.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

K, Gospodarowicz M., und International Union Against Cancer, Hrsg. Prognostic factors in cancer. 2. Aufl. New York: Wiley-Liss, 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Paul, Hermanek, und International Union against Cancer, Hrsg. Prognostic factors in cancer. Berlin: Springer, 1995.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Ulrik, Charlotte Suppli. Prognosis and risk factors for bronchial asthma. København: Lægeforeningens Forlag, 1998.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Hortobagyi, Gabriel N. Stage III breast cancer: Prognostic factors and therapy. Bethesda, MD (Bldg. 82, Rm. 103, Bethesda 20892): U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Th, Büchner, Hrsg. Acute leukemias IV: Prognostic factors and treatment strategies. Berlin: Springer-Verlag, 1994.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

M, Thompson Alastair, Hrsg. Prognostic and predictive factors in breast cancer. 2. Aufl. London: Informa Healthcare, 2008.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Th, Büchner, Hrsg. Acute leukemias: Prognostic factors and treatment strategies. Berlin: Springer-Verlag, 1987.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Grobbee, D. E. Clinical epidemiology: Principles, methods, and applications for clinical research. Sudbury, Mass: Jones and Bartlett Publishers, 2008.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Kataja, Vesa. Genital human papillomavirus (HPV) infections: Prevalence, incidence, risk factors and prognosis. Kuopio: University of Kuopio, 1992.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Waugh, Esther J. factors associated with short-term prognosis of conservatively treated lateral epicondylitis. Ottawa: National Library of Canada, 2002.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Abudu, Adesegun Tiburaniyu. Prognostic factors in primary Ewing's sarcoma of bone. Birmingham: University of Birmingham, 1997.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Th, Büchner, Hrsg. Acute leukemias VI: Prognostic factors and treatment strategies. Berlin: Springer, 1997.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

Th, Büchner, Hrsg. Acute leukemias II: Prognostic factors and treatment strategies. Berlin: Springer-Verlag, 1990.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Pasqualina, Santaguida, United States. Agency for Healthcare Research and Quality. und McMaster University. Evidence-based Practice Center., Hrsg. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. [Rockville, Md: Agency for Healthcare Research and Quality, 2005.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

Gregorini, Paolo. Prognosi riservata: Stato dell'arte della sicurezza in sala operatoria. Milano: Il sole-24 ore, 2008.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Valentine, Andrea. Prognostic factors in transitional cell carcinoma of the bladder (TCCB). [S.l: The author], 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Samuel, Kostrowicki Andrzej, Lityński Marek, Council for Mutual Economic Assistance. und Instytut Geografii i Przestrzennego Zagospodarowania (Polska Akademia Nauk), Hrsg. Natural environment of suburban areas as a development factor of big cities: Papers from a scientific conference of the COMECON subject 1.3 "Evaluation and prognosis concerning the management of natural resources in the development of regions" Jabłonna, Poland, 28.04.-03.05. 1986 : papers from seminars and conferences. Warszawa: Institute of Geography and Spatial Organization, Polish Academy of Sciences, 1988.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Miettinen, Timo. Whiplash injuries in Finland: Incidence, prognosis and predictive factors for the long-term outcome. Kuopio: Kuopion yliopisto, 2005.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Harmsel, Willem Abraham ter. Studies on oncogenesis and prognostic factors in the premalignant and malignant uterine cervix. [Leiden: University of Leiden, 1998.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Wieselgren, Ing-Marie. Prognosis and Early Prognostic Factors in Schizophrenia. Almqvist & Wiksell Internat., 1995.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

WILLIAMS, Betty. Covid 19 Vacccine Guide: Comprehensive Guide on Corona Virus Vaccine, Signs and Symptoms, Host Factor, Causes, Transmission, Prognosis and Prevention. Independently Published, 2021.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Meyrier, Alain, und Patrick Niaudet. Primary focal segmental glomerulosclerosis. Herausgegeben von Neil Turner. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0057_update_001.

Der volle Inhalt der Quelle

Annotation:

Primary focal segmental glomerulosclerosis (FSGS) causes nephrotic syndrome and by definition is not caused by any of the known causes of podocyte toxicity or focal segmental sclerosis such as viral infections or toxins. A number of genetic causes of FSGS are commonly diagnosed in early childhood. Other causes of segmental scarring need to be distinguished. Genotypes in APOL1 of African origin are associated with higher incidence of FSGS and poorer responses to treatment. Cellular and collapsing FSGS are variants of FSGS in which there is overt acute podocytopathy and they have a relatively poor prognosis. A glomerular tip lesion is thought to have a slightly better prognosis than other types. Some cases of primary FSGS respond to high-dose corticosteroids, sometimes only after prolonged therapy. Response to steroids is a good prognostic sign, and without a response, progressive loss of renal function is likely. A circulating factor is implicated by the observation that proteinuria can recur in a donor kidney within hours of transplant. Plasma exchange appears to remove this factor but it is not conclusively identified.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Martin, Albert K. Mesothelioma: Risk Factors, Treatment and Prognosis. Nova Science Publishers, Incorporated, 2021.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Martin, Albert K. Mesothelioma: Risk Factors, Treatment and Prognosis. Nova Science Publishers, Incorporated, 2021.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Chawla, Jatinder, und Swapnil Gupta. Factors Affecting Prognosis or Complicating Treatment. Herausgegeben von Rajiv Radhakrishnan und Lily Arora. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190265557.003.0033.

Der volle Inhalt der Quelle

Annotation:

In this chapter factors affecting prognosis or complicating treatment will be reviewed including genetics, chronicity of illness, insight, adherence to treatment, physical health, primary support group, social environment, economics, access to care and the legal system

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Prognostic factors in cancer. 3. Aufl. Hoboken, NJ: Wiley-Liss, 2006.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Gospodarowicz, Mary K., und Donald E. Henson. Prognostic Factors in Cancer. Island Press, 1995.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Hutter, Robert V. P., Paul Hermanek, Leslie H. Sobin, Donald E. Henson und Mary K. Gospodarowicz. Prognostic Factors in Cancer. Springer London, Limited, 2012.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Graver, Benedict. Septic Shock: Risk Factors, Management and Prognosis. Nova Science Publishers, Incorporated, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Rodgers, Deanna. Myelodysplastic Syndromes: Risk Factors, Treatment and Prognosis. Nova Science Publishers, Incorporated, 2016.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Collier, Bethany R. Ovarian Cancer: Risk Factors, Therapies and Prognosis. Nova Science Publishers, Incorporated, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Guillory, Kevin, und Alex M. Carrasco. Huntington's Disease: Symptoms, Risk Factors and Prognosis. Nova Science Publishers, Incorporated, 2013.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Barrett, Chad L. Abdominal Injuries: Risk Factors, Management and Prognosis. Nova Science Publishers, Incorporated, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Ferrero, Simone. Endometrial Cancer: Risk Factors, Management and Prognosis. Nova Science Publishers, Incorporated, 2018.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Hansen, Donald C. Inguinal Hernia: Risk Factors, Prognosis and Management. Nova Science Publishers, Incorporated, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Naess, Halvor. Long-term prognosis. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198722366.003.0016.

Der volle Inhalt der Quelle

Annotation:

Knowledge of prognosis is important for patients in the prime of life in order to make informed decisions about treatment, choice of education, and profession. Median first-year mortality after first-ever cerebral infarction among young adults is about 4% while median annual average mortality after the first year is about 1.7%. Likewise, median first-year recurrence rate of cerebral infarction is 2% and thereafter 1.5% per year. Risk factors for recurrent cerebral infarction include hypertension, diabetes mellitus, symptomatic atherosclerosis, and smoking. Recurrent cerebral infarction and mortality are associated with increasing number of traditional risk factors. About 10% of patients develop post-stroke seizures within 6 years of the acute stroke. Almost 90% of patients report good functional outcome (modified Rankin Scale score ≤2) on long-term follow-up, but up to 30–50% of patients do not resume employment. Many patients have cognitive impairment. Fatigue and depression are also common on long-term follow-up.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Kourti, Maria, und Emmanouel Hatzipantelis, Hrsg. Prognostic Factors for Pediatric Tumors. MDPI, 2023. http://dx.doi.org/10.3390/books978-3-0365-9702-7.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Derricks, Sherri. Carotid Artery Disease: Risk Factors, Prognosis and Management. Nova Science Publishers, Incorporated, 2014.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Riley, Richard D., Danielle van der Windt, Peter Croft und Karel G. M. Moons, Hrsg. Prognosis Research in Health Care. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198796619.001.0001.

Der volle Inhalt der Quelle

Annotation:

What is going to happen to me, doctor?’ ‘What outcomes am I likely to experience?’ ‘Will this treatment work for me?’ Prognosis—forecasting the future—has always been a part of medical practice and caring for the sick. In modern healthcare it now has a new importance, with large financial investments being made to personalize clinical decisions and tailor treatment strategies to improve individual health outcomes based on prognostic information. Prognosis research—the study of future outcomes in people with a particular health condition—provides the critical evidence for obtaining, evaluating, and implementing prognostic information within modern healthcare. This new book, written and edited by experts in the field, including clinicians, epidemiologists, statisticians, and other healthcare professionals, is a comprehensive and unified account of prognosis research in the broadest sense. It explains the concepts behind prognosis in medical practice and prognosis research, and provides a practical foundation for those developing, conducting, interpreting, synthesizing, and appraising prognosis studies. It recommends a framework of four basic prognosis research types, pioneered by the PROGRESS group, and provides explicit guidance on the conduct, analysis, and reporting of prognosis studies for each type. Key topics are overall prognosis in clinically relevant populations; prognostic factors associated with changes in prognosis across individuals; prognostic models for individual outcome risk prediction; and predictors of treatment effects. Examples are given of the impact of prognosis research across a broad range of healthcare topics, and the book also signals the latest developments in prognosis research, including systematic reviews and meta-analysis of prognosis studies, and the use of electronic health records and machine learning in prognosis research.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff und Amen Sibtain. Colorectal cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0015_update_001.

Der volle Inhalt der Quelle

Annotation:

Breast cancer reviews the epidemiology and aetiology of this malignancy, with particular attention to the genetics underlying familial breast cancer, its pathology along with its receptors, oestrogen receptor (ER), the growth factor receptor HER2, and epidermal growth factor receptor (EGFR), and the bearing these have on treatment and prognosis. The benefits of breast cancer screening in the population and families at higher risk are discussed. Presenting symptoms and signs are followed by investigation including examination, bilateral mammography, and core biopsy of suspicious lesions. Management of non-invasive in situ disease is considered. Invasive breast cancer is staged according to TNM guidelines. Early breast cancer is defined, managed frequently by breast conserving surgery and sentinel node biopsy from the axilla. A positive sentinel node biopsy requires clearance of the axilla. Larger lesions may require mastectomy. Breast radiotherapy is indicated after breast conserving surgery. Following surgery, the risk of systemic micrometastatic disease is estimated from the primary size, lymph node spread, and tumour grade. Adjuvant chemotherapy improves treatment outcome in all but very good prognosis premenopausal breast cancer, and intermediate or poor prognosis postmenopausal breast cancer. This is combined with trastuzumab in HER2 positive disease. Adjuvant endocrine therapy is recommended for all ER positive breast cancer, tamoxifen in premenopausal, aromatase inhibitors in postmenopausal women. Neoadjuvant chemotherapy may be used in large operable breast cancers to facilitate breast conserving surgery. Locally advanced breast cancer is defined, its high risk of metastatic disease requiring full staging before treatment. Systemic therapy is often best first treatment, according to receptor profile. Metastatic breast cancer although incurable can be controlled for years using endocrine therapy, chemotherapy, trastuzumab, palliative radiotherapy, and bisphosphonates as appropriate. Male breast cancer is uncommon, but management similar.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Orth, Stephan R. Smoking in chronic kidney disease. Herausgegeben von David J. Goldsmith. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0103.

Der volle Inhalt der Quelle

Annotation:

Smoking has been acknowledged as the number one preventable cause of death in most countries. The adverse effects of smoking on the kidney are less known. Prospective, population-based, observational studies, and evidence from experimental work indicate that smoking (a) is a relevant risk factor for chronic kidney disease (CKD) in the general population and (b) is associated with an increased risk of deterioration in renal function in CKD patients. The latter is especially true for patients with diabetic nephropathy or hypertensive renal damage. The conclusion is that smoking is an important renal risk factor and nephrologists should make greater efforts to motivate patients to stop smoking, not least because smoking cessation improves the prognosis of CKD.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Coleman, Denise S. Progressive Multifocal Leukoencephalopathy: Risk Factors, Management Strategies and Prognosis. Nova Science Publishers, Incorporated, 2015.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Prognostic Factors in Cancer, 2nd Edition. 2. Aufl. Wiley-Liss, 2001.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Pneumothorax: Classification, Treatment and Prognostic Factors. Nova Science Pub Inc, 2013.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

Screening of tMTHFR, Factor V Leiden and hyperhomocyst(e)inemia: Emerging prognostic factors in myocardial infarction? Ottawa: National Library of Canada, 1999.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Desai, Anjali, und Andrew S. Epstein. Doctors’ Prognostic Accuracy in Terminally Ill Patients (DRAFT). Herausgegeben von Nathan A. Gray und Thomas W. LeBlanc. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190658618.003.0031.

Der volle Inhalt der Quelle

Annotation:

“Doctors’ Prognostic Accuracy in Terminally Ill Patients” reviews one of Christakis and Lamont’s landmark articles, which investigated the factors associated with prognostic accuracy (and prognostic error) in doctors’ prognoses for terminally ill patients. The article explored the extent and determinants of optimistic errors, pessimistic errors, and correct predictions among doctors who were estimating prognoses for their terminally ill patients. This chapter offers a concise breakdown of the study’s design and salient study results while also pointing out study limitations. The chapter summarizes other relevant studies exploring prognostic estimates and prognostic disclosure by physicians to terminally ill cancer patients. Finally, the chapter provides a clinical case to illustrate some of the study’s practical implications for patient care.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!